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1. Introduction 
Amyloidoses from a group of disorders characterized by extracellular tissue accumulation 
of amorphous hyaline material. They are categorized in two main forms: systemic and 
localized (Zhuang YL, 2005). Localized forms involve a single organ, whereas systemic 
amyloidosis involves multiple organ systems. 
Localized forms often involve the head and neck. The aerodigestive tract is a common location, 
the nasopharynx or soft palate are rarely envaded (Panda NK, 2007) (Pitkäranta A, 2000). 
The distinction between localized and systemic disease is important because localized 
amyloidosis can be managed conservatively with an excellent prognosis, whereas systemic 
amyloidosis is associated with significant morbidity and mortality (Kyle RA, 1975). 
Although the pathogenesis is not completely understood, soluble protein subunits undergo 
a conformational change to become insoluble and aggregate in an antiparallel β-pleated 
sheet conformation (Panda NK, 2007). The diagnosis of amyloidosis is made based on 
Congo red staining on tissue biopsy which leads to apple-green birefringence on polarized 
microscopy (Patel A, 2002). 
Amyloidomas are benign tumorlike lesions consisting of localized deposits of amyloid and 
are the rarest form in the group of amyloidosis-related lesions (Parmar H, 2010). 
Amyloidosis should not be considered as a single clinical entity, but rather as a 
nonhomogeneous group of diseases characterized by the common presence of a fibrillar 
structure of linear, aggregated fibers with a cross β-pleated sheet conformation, and 
evidenced by x-ray diffraction. In primary amyloidosis, a monoclonal population of marrow 
cells produces either fragments of light chains that may be processed to form amyloid. 
Secondary amyloidosis is characterized by a defect in the metabolism of the precursor 
protein (Comenzo RL, 2006). 
Our objective is to study the epidemioloclinical characteristics of ENT amyloidosis and the 
management of those localizations. 
2. Study method 
Data Sources a systematic literature search of MEDLINE, SCIENCEDIRECT and Web of 
Science Review Database from 2000 to 2010 was conducted using specific search terms: head 
and neck amyloidosis, localized amyloidosis, ENT Diseases, hypopharynx, larynx, oral 
cavity, oropharynx, nasopharynx and sinonasal cavities.  
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We considered thirty-three articles for our review and including a total of 43 patients.  
Exclusion criteria were: systemic amyloidosis, a concomitant history of chronic inflammatory 
processes, monoclonal gammopathy and myeloma. 
3. Epidemiology 
Localized amyloidosis is characterized by the same staining properties as systemic 
amyloidosis but is usually fortuitously diagnosed. 
The majority of patients with head and neck amyloidosis have no underlying chronic 
systemic disease (primary form).  
Nasal or nasopharyngeal amyloidosis is a very rare condition with few case reports seen in 
the English scientific literature. Both sexes may be affected, with a great variation in age of 
disease onset (8–86 years old). Laryngeal involvement in amyloidosis is rare and accounts 
for less than 1% of all benign laryngeal tumors. It usually occurs in the 40–60 years age 
range with a male to female predominance of about 2:1 (Gallivan GJ, 2010). 
3.1 Age and sex 
The mean age of patients considered in our review was 52,36 years with ages ranging from 
10 to 86 years; 21 were male and 22 were female. 
3.2 Localization 
This literature review identified 33 articles describing a total of 43 cases of localized head 
and neck amyloidosis, summarized in Table 1. 
 
Localization 
Number 
of cases 
Mean age Male Female 
Larynx 12 47,5 6 6 
Nasopharynx 7 55,5 4 3 
Tongue 6 58 4 2 
Palate 4 66,7 1 3 
Trachea 3 52,3 2 1 
Hypopharynx 3 55,3 0 3 
Sinonasal 
cavities 
2 32,5 0 2 
Oropharynx 1 12 0 1 
Tonsil 1 71 1 0 
Ear 1 47 1 0 
Cervical 
lymph nodes 
3 60 2 1 
Table 1. Epidemiological characteristics of localized amyloidosis 
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Localized amyloidosis is an uncommon benign disorder which occurs most commonly in 
the head and neck region.  
Among the sites, larynx is affected most frequently (61%), followed by oropharynx (23%), 
trachea (9%), and orbit (4%) (Glenner GG, 1980) (Scott PP, 1986). Only 3% of cases occur in 
the nasopharynx (Glenner GG, 1980) (Scott PP, 1986). In the larynx, the most commonly 
involved sites are the vestibular fold, followed by the subglotis, ventricle, vocal folds, and 
aryepiglottic folds.  
Chin et al. reported a case of localized amyloidosis involving simultaneously the sinonasal 
cavities and the larynx (Chin SC, 2004). 
Localized amyloidosis of the nasal mucosa is extremely rare with few cases reported in the 
English literature (Pearlman AN, 2010). 
Localized amyloidosis of the palate is extremely rare and only five cases have been reported 
(Aono J, 2009). 
Amyloidosis of Waldeyer’s ring has been also described (Walker PA, 1996). 
The hypopharyngeal involvement is extremely rare: extensive search of the literature 
retrieved only 3 primitive localized hypopharyngeal amyloidosis (Ghekiere O, 2003) 
(Bhavani RS, 2010) (Penner CR, 2006).  
Amyloidosis in the external auditory canal is extremely rare. Indeed, only 13 cases have 
been reported worldwide to date (Yamazaki K, 2011). 
Only two cases report of localized amyloidosis of the parotid glands were described in the 
literature (Stimson PG, 1988) (Nandapalan V, 1998). 
No case of localized submandibular amyloidosis has been reported. 
Kurokawa (Kurokawa H, 1998) reported the first case of primary localized of the sublingual 
gland. 
4. Clinical features 
There are currently 3 known forms of amyloidosis. 
The first, primary systemic amyloidosis is a systemic condition with no known underlying 
cause. It is different from the secondary systemic amyloidosis, which occurs with other 
underlying medical problems, such as tuberculosis and rheumatoid arthritis. And this form 
also includes patients with multiple myeloma, of which 10% to 20% have associated 
amyloidosis (Kyle RA, 1975) (Gertz MA, 2005). Renal and cardiac diseases are seen in both 
primary and secondary systemic forms and are the most frequent causes of death (Kyle RA, 
1975). Other symptoms may include hypesthesias, syncope, macroglossia, and carpal tunnel 
syndrome. The third form of amyloidosis is localized and which occurs without any 
evidence of systemic involvement or underlying disease.  
In a review of 236 cases of amyloidosis, Kyle and Bayrd (Kyle RA, 1975) found that only 22 
cases (9%) were localized. None of these patients developed systemic disease in a 10-year 
follow-up. Similarly, in the University of California, Los Angeles series, localized amyloidosis 
did not evolve to primary or secondary systemic amyloidosis or multiple myeloma (Kerner 
MM, 1995). 
Localized amyloidosis is a clinical entity with variable presentation, depending on the 
organs involved. 
Clinically, amyloidosis can manifest in several different forms: primary versus secondary, 
heredofamilial versus acquired, and generalized versus localized.  
The most frequent types encountered in clinical practice are the amyloid light chain (AL, 
primary) and a protein called the AA protein (secondary), both of which might involve 
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multiple organ systems (kidney, heart, and liver). In our literature review we analyzed the 
articles about localized amyloidosis 
Isolated deposition of fibrillar proteins in an organ may result in organ-specific syndromes 
(e.g. Alzheimer’s disease and primary localized amyloidosis of the bladder) (Malek RS, 
2002). In the head and neck region, the most common site of amyloid depositions is the 
larynx, and other sites include the orbit, skin, tongue, salivary glands and cervical lymph 
nodes (Pribitkin E, 2003).  
The presentation of head and neck amyloidosis varies according to the site of involvement. 
A patient can present with nasal obstruction, epistaxis (due to vessel wall invasion), glue 
ear, dysphagia, foreign body sensation in the throat, and voice change, but most of the cases 
of oropharyngeal amyloid are asymptomatic (Mufarrij AA, 1990).  
They will appear as yellowish mucosa, covered, and irregular polypoidal lesions (Mufarrij 
AA, 1990). 
4.1 Sino-nasal and nasopharyngeal amyloidosis 
The presenting symptoms consist of nasal obstruction, recurrent epistaxis, postnasal drip 
and ear problems due to eustachian tube obstruction with resultant middle ear effusion 
(Pang KP, 2001) (Patel A, 2002).  
Facial pain can be seen in amyloidosis of the maxillary antrum (MCALPINE JC, 1964). 
Occasionally, it may manifest as a clinical picture simulating an apparent malignancy with 
cervical nodal metastasis (Zhuang YL, 2005).  
Generally, the appearance is described as a yellowish or whitish polypoid, firm mass. 
Macroscopically, organs infiltrated with amyloid have a characteristic firm, rubbery firm 
consistency, but may also be nodular-like or irregular, mimicking neoplasm. A waxy, gray 
or yellowish appearance is also typical (Pribitkin E, 2003). 
Geller et al (Geller E, 2010) reported the first case of localized nasopharyngeal amyloidosis 
causing bilateral nasolacrimal duct obstruction.  
This localization has usually a slow evolution. 
4.2 Larynx 
Laryngeal amyloidosis remains a rare entity accounting for about 1% of all benign laryngeal 
tumors. Within the larynx, a number of sites can be involved including ventricular folds 
(55%), laryngeal ventricle (36%), subglottic space (36%), vocal folds (27%), aryepiglottic folds 
(23%) and anterior commissure (14%) (Passerotti GH, 2008). 
Clinical manifestations are hoarseness, dyspnea, cough, stridor, and rarely, hemoptysis. 
(Finn DG, 1982) 
The lesion is usually a firm, nonulcerated yellow, orange, or gray submucosal nodule, mass 
or pedunculated polypoid lesion.  
It is rare for vocal fold fixation or cicatricial stenosis to occur unless other predisposing 
factors are also present (Caldarelli DD, 1979). A cystic lesion (Talbot AR, 1979) or infiltrating 
tumor of the vocal folds and subglottis, multinodular subglottic, tracheal, mainstem 
bronchial and pulmonary deposits may occur (Simpson GT 2nd, 1984).  
4.3 Tracheobronchial 
Respiratory symptoms may vary according to the anatomic deposition of amyloid (Gillmore 
JD, 1999). Patients with upper tracheal or proximal airway disease develop varying degrees 
of airway obstruction. They have worse prognosis than those with distal airway 
involvement (Utz JP, 1996).  
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Common presenting symptoms are dyspnea, cough, and wheezing. These symptoms are not 
specific and may mimic different pathologies, such as asthma, chronic bronchitis, and 
endobronchial tumor. Those with distal tracheal and bronchial disease may have atelectasis, 
recurrent pneumonias, or bronchiectasis (Thompson PJ, 1983).  
4.4 Hypopharynx and upper esophagus 
The presenting symptoms consist of progressive dysphagia to both solids and liquids. 
Nasofibroscopy and endoscopy found salivary stasis in the pyriform sinus with regular 
swelling with normal mucosa amyloidosis (Ghekiere O, 2003) (Bhavani RS, 2010). 
4.5 Oral cavity 
Amyloid involvement of tongue is almost always secondary to systemic amyloidosis and 
localized involvement is extremely rare (Fahrner KS, 2004).  
Oral amyloidosis usually appears as multiple soft nodules, sometimes hemorrhagic, which 
can cause macroglossia (Asaumi J, 2001). Alternatively the nodular masses may resemble 
benign tumors such as granular cell tumors, schwannomas, neurofibromas and neuromas 
(Muto T, 1991). 
Yellow nodules or raised white lesions occurring predominately along the lateral border are 
also common. 
Sometimes petechiae, ecchymoses and hemorrhagic blisters can also be observed (van der 
Waal RI, 2002). 
Primary localized amyloidosis of the palate is extremely rare and only a few cases have been 
reported (Balatsouras DG, 2007) (Stoor P, 2004) (Alvi A, 1999). 
This type of lesion tends to spread locally and occasionally may result in bleeding, epistaxis, 
and middle ear effusion. 
4.6 Cervical lymph nodes 
Few documented cases of isolated amyloidosis of cervical lymph nodes have been reported 
(Shi Q, 2000) (Bielsa S, 2005).  
4.7 Amyloid goiter 
Amyloid goiter is a rare pathology due to massive amyloid infiltration of thyroid tissue, 
which causes diffuse or localized enlargement of the gland. It can be totally asymptomatic or 
causes only non-specific symptoms (compression of adjacent structures, tracheal deviation). 
Thyroid dysfunction (hypothyroidism or hyperthyroidism) is rare (Cavallaro G, 2006).  
4.8 Ear 
Physical examination demonstrates brownish or red mass that occupied ear canal, 
eventually blocked the visualization of the tympanic membrane associated with conductive 
hearing loss in tone audiometry (Yamazaki K, 2011). 
It’s like an otitis externa that did not respond to local treatment.  
5. Diagnosis 
Localized amyloid tumors in the head and neck region are an extremely rare manifestation 
that is not usually associated with either multiple myeloma or systemic amyloidosis 
(Godbersen GS, 1992). 
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Amyloidosis is a disease complex resulting in the extracellular deposition of waxy insoluble 
fibrillar protein material called “amyloid.” It was first described by Rokitansky in 1842 
(Rokitansky K, 1842). Amyloid consists of relatively insoluble fibrils composed of 
polypeptide chains arranged in a twisted ß-pleated sheet configuration. This particular 
protein configuration accounts for its characteristic staining properties and permits 
identification by light microscopy. It imparts unique chemical properties like resistance to 
protease digestion and insolubility, which promote continued deposition within organs. 
Therefore a biopsy from the head and neck that reveals amyloid necessitates evaluation for 
systemic involvement either by rectal biopsy (75% positive) or fat aspiration of the anterior 
abdominal wall (90% positive) (Nandapalan V, 1998). The absence of Congo red staining of 
biopsy specimens from either of these 2 sites establishes that the amyloidosis is not systemic 
(Simpson GT 2nd, 1984). Specific organ involvement may also be excluded by laboratory or 
radiologic studies (Nandapalan V, 1998). 
While amyloid can be suspected on routine hematoxylin-eosin sections, special stains are 
important for definitive diagnosis. With the polarized microscope, amyloid is seen to have a 
green birefringence when stained with Congo red. 
The etiology, treatment, and outcome of systemic amyloidosis are totally different from 
localized amyloidosis. The mean survival of patients with systemic amyloidosis is between 5 
to 15 months, whereas patients with localized amyloidosis have excellent prognosis 
(Fahrner KS, 2004). 
Final diagnosis relied on histopathological analysis of endonasal endoscopic biopsy samples 
taken under local or general anesthesia (Yakoot A, 2010).  
Histopathological examination showed eosinophil areas, staining positively on Congo red 
(expressing birefringence under polarized light and on thioflavin) (Yakoot A, 2010). 
 These histologic features indicated a diagnosis of amyloidosis without signs of underlying 
malignancy (no abnormalities on general check-up). 
On Congo red staining, green birefringence is revealed under polarized light, and electron 
microscopy shows 8–10-nm wide, straight, and unbranching fibrils. 
6. Radiology 
The computed tomography (CT) provides excellent information on the anatomic location 
and topography of different laryngeal benign lesions (Aspestrand F, 1989) but cannot be 
used to differentiate inflammatory masses from benign neoplasms. 
Computed tomography scans demonstrate focal amyloidosis as a well-defined, submucosal, 
homogeneous, hyperdense, soft tissue mass in association with calcifications (Gean-Marton 
AD, 1991) (Panda NK, 2007) (Pitkäranta A, 2000). 
The lesions are described as well-defined homogeneous soft-tissue masses, with no or only a 
slight degree of contrast enhancement (Godbersen GS, 1992).  
Occasionally, areas of localized calcification within the mass are present (Hegarty JL, 1993) 
(Parmar H, 2010).  
Although the amyloidosis does not generally induce osteolysis, one case of nasopharyngeal 
amyloidosis with sinus extension and bone destruction suggestive of malignancy has been 
reported (Zhuang YL, 2005). 
MRI is considered as the technique of choice for diagnosis, showing characteristic aspects: 
intermediate T1-weighted signal and T2-weighted hyposignal, as in striated muscle, without 
modification in fat-suppression sequences (Zhuang YL, 2005). This signal pattern is due to 
the amyloid protein deposits, which are fibrillar as in striated muscle fiber (Gilad R, 2007).  
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The laryngeal lesion reveals intensity equal to that of surrounding muscles on T1 and 
remains isointense or slightly hyperintense on T2. In comparison, chondrosarcoma of the 
larynx is hypo- to isointense on T1 and hyperintense on T2, which parallels the appearance 
of mature hyaline cartilage. Therefore, T2 signal-intensity characteristics might help 
differentiate amyloidoma from chondrosarcoma. 
Following administration of a contrast agent, the lesion exhibits slight or no enhancement. A 
“fluffy” appearance of bones surrounding the lesion has been shown, which is thought to 
result from an osteoblastic reaction provoked by submucosal deposition of amyloid fibrils 
(Chin SC, 2004).  
MRI studies show a submucosal mass with low signal intensity in both T1- and T2-weighted 
images, and mild enhancement in postcontrast T1-weighted images. However, Motosugi et 
al. (Motosugi U, 2007) reported a case of localized nasopharyngeal amyloidosis which 
showed high signal intensity on T2-weighted images and marked early enhancement in the 
periphery of the mass on dynamic contrast-enhanced MRI. This phenomenon was attributed 
to plasmacyte infiltration which occasionally occurs with amyloidosis, leading to 
hypervascularity. 
The exact mechanism underlying the signal hypointensity of amyloid in T2-weighted 
images is unknown. There are 3 possible mechanisms described (Gean-Marton AD, 1991): 
(1) signal loss results from enhanced T2 decay because of the presence of static or slowly 
fluctuating internal magnetic fields within adjacent amyloid proteins held in fixed positions 
within the folded protein; (2) rapid chemical exchange and spin-spin interactions may occur 
between the amyloid protein and adjacent water molecules; and (3) because the amyloid 
microenvironment is composed of a heterogeneous micromagnetic mixture of collagen, 
calcification, and vessels as well as the amyloid fibrils, the T2 hypointensity may result from 
differences in diamagnetic susceptibility (Gean-Marton AD, 1991). 
7. Differential diagnosis 
7.1 Systemic amyloidosis 
Localized amyloidosis has been described in nearly every organ system. Development of 
systemic disease following a diagnosis of localized amyloidosis was rare, occurring in 2% of 
cases. One-quarter of patients with primary systemic amyloidosis presents with clinical 
involvement of only one organ, but investigation leads to the recognition of widespread 
involvement (Merlini G, 2003). 
7.2 Larynx 
In the larynx, the amyloid deposits are submucosal and homogeneous and are not 
associated with the cartilage changes.  
They are firm lesions that tend to occur in the supraglottic larynx, although all laryngeal 
sites may be affected.  
The differential diagnosis includes other submucosal diseases such as laryngeal sarcoidosis, 
lymphoma, and pseudotumor. 
7.3 Tracheobronchial 
Wegener’s granulomatosis, laryngotracheobronchial papillomatosis, idiopathic 
laryngotracheal stenosis, sarcoidosis, or tracheobronchitis with ulcerative colitis may 
radiologically mimic tracheobronchial amyloidosis. 
www.intechopen.com
 
Amyloidosis – An Insight to Disease of Systems and Novel Therapies 
 
134 
7.4 Tongue 
There is a wide differential diagnosis that should be considered in patients presenting with 
macroglossia or nodular tongue lesions. 
For generalized macroglossia, amyloid, tuberculosis, lymphangioma, hypothyroidism, 
acromegaly, lingual infarction caused by giant-cell arteritis, idiopathic muscular hypertrophy, 
and Beckwith-Wiedemann syndrome should be considered. 
For nodular lesions, fibroma, lipoma, granular cell tumor, sarcoma, lingual thyroid. and 
salivary gland tumors would be among the differential. 
7.5 Palate 
The differential diagnosis includes candidiasis, vascular lesions and Kaposi’s sarcoma. 
7.6 Amyloid goiter 
Microscopic infiltration of the thyroid gland by amyloid is an uncommon but well 
recognized phenomenon and significant enlargement of the thyroid due to deposition of 
amyloid is rarely seen. This condition has to be distinguished from other types of goiters 
and at times from malignancy. 
Amyloid goiter may be diagnosed by cytopuncture (Kapadia HC, 2001), although there is a 
problem of differential diagnosis with medullary carcinoma, where amyloid deposit is also 
found in 50% to 80% of cases.  
However, cytopuncture excludes other thyroid cancers, notably anaplastic cancer and 
lymphoma.  
Anatomopathology enables positive diagnosis in case of amyloid deposit detected in the 
form of an amorphous substance showing yellow-green double refraction under polarized 
light on Congo red staining. 
7.7 Sino-nasal and nasopharyngeal amyloidosis 
The differential diagnosis for lesion within the maxillary antrum includes malignant 
conditions such as squamous cell carcinoma, lymphoma, metastatic disease, plasmacytoma, 
melanoma, neuroblastoma, paraganglionoma and haemangiopericytoma, benign lesions 
including hamartoma, and local fungal infections such as mucormycosis and aspergilloma 
(Birchall D, 1997). 
Although amyloidoma of the nose is rare, it should be considered as part of the differential 
diagnosis of a nasal mass presenting with nasal obstruction and epistaxis, even in pediatric 
patients. The approach should include a scan to exclude a possible vascular tumor, the as 
the appearance may be fleshy. 
Because of its infrequent occurrence, nasopharyngeal amyloidosis is rarely considered in the 
differential diagnosis of nasopharyngeal tumor (Panda NK, 2007). Initial endoscopic 
examination in the present case was rather suggestive of adipose tumor. 
8. Treatment 
In systemic disease, high-dose chemotherapy followed by stem cell reconstitution seems to 
provide the most effective treatment (Gertz MA, 2005). 
The localized amyloidosis has excellent prognosis and never evolves towards systemic 
forms (Pitkäranta A, 2000). Hence, it may be treated with surgical excision (Stoor P, 2004) , 
especially to reduce local soft palate mass (Zhuang YL, 2005) (Pitkäranta A, 2000).  
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Certain reports consider surgery for nasopharyngeal forms to be merely palliative (Stoor P, 
2004). In case of recurrence, surgical revision may be recommenced, depending on 
symptomatology.  
For localized amyloidosis, symptomatic removal is required. But, close follow-up is 
necessary because the recurrence rate reported is as high as 50%.  
8.1 Sinonasal cavities and nasopharynx 
For localized amyloidosis of the nasopharynx, surgical resection is usually chosen as the 
treatment modality for symptomatic relief. However, the extent of surgical excision has 
changed from radical excision to a more conservative approach.  
The rationale behind this alteration is that a conservative surgical approach may be 
associated with a slower rate of recurrence (Lesserman JA FD, 1995). Unfortunately, failure 
to prevent recurrence by means of surgical excision has been found in the majority of case 
reports. Simpson et al. (Simpson GT 2nd, 1984) have suggested a reduction in the recurrence 
rate following laser resection.  
Emerging treatment approaches employing agents that disrupt fibril formation, destabilize 
amyloid deposits, or interfere with interaction between amyloidogenic proteins and 
accessory molecules have shown promising results in animal models, and clinical 
applications are underway (Lachmann HJ, 2003). 
The surgical treatment must be done in case of airway obstruction, bleeding, and other 
severe symptoms.  
Radiotherapy may be a treatment option in nasal and nasopharyngeal amyloidosis. 
Symptoms may be improved with steroid treatment (Pearlman AN, 2010). 
8.2 Larynx 
It is important to treat laryngeal amyloidosis because untreated cases can progress to vocal 
fold fixation, severe dysphonia, and airway obstruction. Alternatively, "expectant" 
management with no intervention may be indicated in certain carefully selected cases, 
owing to the slow progression of the disease over many years (Avitia S, 2007). 
In isolated laryngeal amyloidosis, treatment is primarily endoscopic surgical removal of 
masses that interfere with laryngeal or airway function. The likelihood of recurrent or 
residual disease is significant (Talbot AR, 1979). 
Because of the propensity of amyloid to infiltrate blood vessels, cold resection of amyloid 
lesions may be complicated by bleeding. Although CO2 laser excision may be advantageous, if 
used in very extensive lesions, there may be scarring (Talbot AR, 1979) (Simpson GT 2nd, 
1984). 
In very large lesions, external approaches, employing laryngofissure for treatment of diffuse 
subglottic and tracheal amyloidosis have been used. Repeated excision and curettage may 
be necessary to achieve stabilization of lesions and subsequent decannulation of those 
patients who are tracheotomy dependent.  
Local or systemic steroids are ineffective in controlling or reversing lesions of amyloidosis 
(Finn DG, 1982). 
Bartels et al (Bartels H, 2004) found five patients over a period of 13 years who had localized 
laryngeal amyloidosis and free light chains were found in one patient. Amyloid interfering 
with laryngeal or airway function was excised during microlaryngoscopy. Cold endoscopic 
excision for glottic deposits and CO2 laser for supraglottic lesions provided best results. 
Four patients developed recurrent disease. 
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IMRT: Intensity Modulated Radiotherapy  
Table 2. Distribution by the therapeutic procedure 
Dedo and Izdebski (Dedo HH, 2004) reported 10 consecutive laryngeal amyloid patients in 
whom amyloid was found on the undersurface of both vocal folds in two and submucosally 
in unilateral or bilateral vestibular folds in eight cases. Direct microlaryngoscopy with CO2 
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laser excision was done on one side at a time to try to prevent anterior commissure scarring. 
Followup after the first operation was 6 months to 16 years, with an average of 6.5 years. 
Four vestibular fold patients required re-excision on the same side after the first operation. 
Because full resection is difficult, Neuner GA (Neuner GA, 2010) recommends a combination 
of surgery and radiation therapy to cure localized amyloidosis of the larynx.  
Other treatments options that have been described include corticosteroids, radiotherapy, 
and agents like colchicine and melphalan. However, these modalities have yielded variable 
results (Avitia S, 2007). 
8.3 Trachea 
The management is dependent on symptoms. Treatment options are bronchoscopic 
approaches, surgery, radiation, and observation. Therapy may not be required for 
asymptomatic patients. Cases with proximal airway obstruction are difficult to manage.  
Bronchoscopic methods are mechanical debulking, endobronchial laser ablation, and stent 
or balloon dilatation in selected patients with stenosis. These methods are preferable and 
safer than surgery. However, such methods may be ineffective and repeated procedures 
may be required (Gillmore JD, 1999) (O'Regan A, 2000). Bleeding is a common complication 
of these procedures.  
Sometimes external beam radiation or surgical resection is necessary (Neben-Wittich MA, 
2007). 
8.4 Oral cavity 
The definitive treatment of localized amyloidosis was cited to be surgery. Surgery alone 
may be 100% curative (Fahrner KS, 2004). 
8.5 Cervical lymph node 
There is no specific treatment for this uncommon entity (Bielsa S, 2005). The cervical lymph 
nodes dissection may be done (Shi Q, 2000). 
8.6 Amyloid goiter 
Fine-needle aspiration biopsy can be performed to exclude malignant lesions. In order  
to diagnose amyloid goiter, definitively thyroidectomy is often necessary. Surgical 
intervention is indicated either for aesthetic purposes or to relieve the pressure symptoms 
(Villa F, 2008). 
9. Conclusion 
Amyloidosis is a rare disease with multifactorial pathogenesis.  
Localized amyloidosis affecting the head and neck region is an uncommon and benign 
process, which has almost no clinical consequences. Once the diagnosis has been made, an 
extensive workup for systemic amyloidosis should be undertaken. This should include 
abdominal fat biopsy or rectal biopsy. 
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